My thoughts- The company has the H1- a 4 k streaming device priced similarly to the sony player. The H1 has been around 9 months- The company has had a 4k streamer for a long time now. The company has big names involved who also have big contacts. Why is Jeff Foley buying so many shares- He obviously knows what we dont. Seeing what his brother has been through for the past 10 years I really dont think he would be involved in any type of fraud. We have 50 employees- what other pink has that? We can go visit any of the sites including the 4k remastering. How many of those machines do we have 2 or 3? They are either making money doing remastering for other companies or making content for a Netflix like channel. The channel alone could be worth a small fortune. Didnt A Taylor mention a deal with a film studio? Dont ya think they want to get out of the pinks in order to profit from the number of shares they have? Of course they do. I for one think audited fins will be here- hopefully next month. Doesnt having our product at NAB show say anything to give you confidence? Some people buy houses and rent them out hoping that in 20 to 30 yrs they can sell those houses for a nice profit. Look at the fact the sceduled the shareholders meeting early this yr knowing that small mods were being made to the NP1. They know the shareholder at the meeting would be pissed if they didnt have something positive to show. Scam companies dont do this. Why do bashers show up in droves to the ihub site? some KNOW this is a company they want shares in as they know it will be huge someday. Bashing to get more shares is understandable. I have said from a long time ago that those with huge amount of shares can cause this to be volitile- We need to uplist. This is the only way we can get bigger investors in here to get us out of pennies and Im sure management knows this.
My thoughts- The company has the H1- a 4 k streaming
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Kenox Pharmaceuticals Revolutionizes Drug Development Landscape
Revolutionizing Drug Development Approaches Kenox Pharmaceuticals Inc, a leading name in the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs), has recently announced an exciting extension of its capabilities. The introduction of small scale non-sterile GMP capabilities marks a significant enhancement to its already comprehensive drug development...
Continue Reading
Exciting Listing of AI-themed ATC Coin on CoinW Exchange
Exciting Listing of AI-themed ATC Coin on CoinW Exchange CoinW, recognized as a trailblazer in the realm of cryptocurrency trading platforms, is thrilled to announce the listing of ATC, an innovative meme coin designed around artificial intelligence. ATC will be available for trading in both AI, MEME, and SOL Zones. To celebrate this momentous occasion, which marks an...
Continue Reading
Webstar Technology Group’s Innovative Blockchain Venture
Revolutionizing Real Estate with Blockchain Tokenization Webstar Technology Group (OTCMKTS: WBSR) is stepping into the future with a bold initiative that harnesses the power of blockchain technology for real estate ventures. This forward-thinking approach not only highlights the company's commitment to innovation but also positions it as a leader in the rapidly evolving...
Continue Reading
Class Action Lawsuits Update: ATYR, MLTX, BAX, JHX
Overview of Recent Class Action Lawsuits Several publicly traded companies are facing legal challenges with class action lawsuits initiated on behalf of their shareholders. It's crucial for investors in these companies to be aware of their rights and the deadlines for potential legal actions. This article discusses the companies involved and provides essential information...
Continue Reading
Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing
Partnership Expansion Between Biodesix and Bio-Rad Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications....
Continue Reading